Search

everythinglearnresearchcommunity

for

Search:↓

Primary care is key in managing PCOS, focusing on lifestyle changes and medications like birth control and metformin.

Young men with early hair loss have slightly worse blood sugar and fat levels, suggesting possible health risks and need for monitoring.

Women with low SHBG levels and a high 3a-diol G to SHBG ratio are likely to experience female pattern baldness, possibly due to a slight excess of androgens affecting sensitive hair bulbs.

Hormones, especially androgens, play a key role in acne, which can be a symptom of systemic diseases like PCOS and may require targeted treatment.

Insulin-lowering medications show promise for PCOS symptoms but can't be the main treatment yet due to limited long-term research.

Low-dose oral minoxidil effectively reduces hair loss in women with female pattern hair loss.

Hirsutism causes significant psychological distress in women.

Hidradenitis suppurativa may be related to hormones and patients often have metabolic disorders; more research is needed to understand this connection.

Excessive hair growth in women often has no known cause and is not linked to race or other hormonal symptoms.

Male hormones affect COVID-19 severity and certain drugs targeting these hormones could help reduce the risk.

Methotrexate treatment for rheumatoid arthritis has a serious infection rate of about two per 100 patient-years.

Lower nitric oxide and higher fibrinogen found in hirsute women; impaired sexual function in 22.6% of hair loss patients, linked to psoriasis severity.

Older men with low levels of a testosterone byproduct had a higher chance of developing an irregular heartbeat.

Metformin combined with lifestyle changes improves insulin resistance and reduces testosterone levels in women with PCOS more than lifestyle changes alone.

Severe and early hair loss may indicate a higher risk of heart disease.

Higher leptin and lower vitamin D levels may contribute to male pattern baldness.

Insulin resistance may contribute to hair loss in people with androgenic alopecia.

Minoxidil works better for female hair loss, but cyproterone reduces scalp oiliness and causes menstrual issues.

Idiopathic hirsutism causes excessive hair growth in women, can be treated with medication and hair removal, but cannot be fully reversed.

Larger ovarian size is linked to higher insulin resistance in women with PCOS.

Aldactone was more effective in reducing hair growth in women with hirsutism than Diane, despite having less impact on hormone levels.

PCOS management includes lifestyle changes and medications, with ongoing research into repurposed drugs for better treatment options.

Different treatments for PCOS focus on the specific symptoms, with weight loss and lifestyle changes being important.

Skin symptoms can indicate endocrine disorders and have various treatments.

Insulin resistance is a key factor in polycystic ovary syndrome, but genetics may also contribute.

Metformin and rosiglitazone both improved insulin use and hormonal symptoms in women with PCOS.

Menopause affects hair and skin; more research needed for treatment.

Male hormones are important for hair and oil gland development and can cause conditions like excessive hair growth and acne.

Women with PCOS are more likely to have fatty liver disease and worse metabolic health.

Cyproterone acetate is the preferred treatment for women's hyperandrogenism when estrogen/progestogen use is safe.